Next Generation Sequencing

CYP Genetic (Genotyping) Testing! Precision Medicine in Toxicology Drug Interactions and Labeling

By |2022-01-12T13:59:09-06:00December 27th, 2016|Next Generation Sequencing, Toxicology|

Cytochrome P450 (CYP450) tests help determine how your body processes (metabolizes) or responds to medications. We look for variations in cytochrome P450 genes that can affect the breakdown of medications. Depending [...]

Mass Spectrometry – Proteomics – Metabolomics – for Disease – Specific Biomarkers

By |2022-01-12T14:00:00-06:00December 22nd, 2016|Genetic Testing, Mass Spectrometry, Next Generation Sequencing, Research|

The Proteomics studies that corroborate Metabolomics findings are the next generation of laboratory testing using the Mass Spectrometry, a key technology for targeted protein and metabolite identification and quantification. This [...]

Solid Tumor NGS DNA Testing!

By |2017-01-19T11:29:00-06:00December 16th, 2016|Genetic Testing, Next Generation Sequencing, Solid Tumor|

At Ayass BioScience, we use high-throughput Next Generation Sequencing technology to sequence cancer patients' solid tumor DNA (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer). Targeted sequencing of tumor DNA across our [...]

ctDNA Detection – CLIA Compliant Lab Developed Test!

By |2022-01-12T14:00:48-06:00December 8th, 2016|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing|

Ayass BioScience Circulating Tumor DNA (ctDNA) Assay is CLIA Compliant Lab Developed Test for Clinical Practice. Ayass BioScience ctDNA detects low levels of circulating tumor DNA (ctDNA) in the blood stream [...]

“Liquid Biopsy” for ctDNA Detection – A New Generation of Cancer Biomarker!

By |2022-01-12T14:02:16-06:00November 30th, 2016|Circulating Tumor DNA, Next Generation Sequencing|

Detecting low levels of circulating tumor DNA (ctDNA) in the blood stream using NGS technology is a minimally invasive method to detect the presence of tumor DNA that is shed [...]

Next Generation Sequencing of Solid Tumor DNA

By |2020-05-17T17:37:54-05:00November 8th, 2016|Breast Cancer, Genetic Testing, Next Generation Sequencing, Solid Tumor|

Precision medicine is personalized medical care based on the genetic profiles of patients. At Ayass BioScience, we use high-throughput Next Generation Sequencing technologies to sequence cancer patients' solid tumor DNA. [...]

Circulating Tumor DNA – Highly Sensitive and Robust Variant DETECTION AND MONITORING

By |2016-11-03T11:37:37-05:00October 28th, 2016|Circulating Tumor DNA, Genetic Testing, Next Generation Sequencing|

Circulating tumor DNA (ctDNA) are pieces of DNA from dying cancer cells found in the blood of cancer patients. At Ayass BioScience, we are utilizing a minimally invasive method that [...]

Free Genetic Testing with Blood Donation!

By |2022-01-12T14:03:34-06:00October 25th, 2016|Genetic Testing, Next Generation Sequencing, Offers, Research|

The role of genetic research is indispensable in diagnosis and treatment of genetic disorders. We study how each genes work and what roles genes have in the development of disease. [...]

Donate and find out about your “blue print”!

By |2022-01-12T14:04:37-06:00October 20th, 2016|Genetic Testing, News from Ayass BioScience, Next Generation Sequencing, Offers, Research|

If you or a loved one has been diagnosed with Lung, Colon, Prostate, or Breast Cancer, we are currently offering genetic testing at no cost to you other than a [...]

Be a Part of Very Important Research

By |2022-01-12T14:06:09-06:00October 18th, 2016|News from Ayass BioScience, Next Generation Sequencing, Research|

Contribute to important research and make a difference today! You are invited to participate in a research study on hereditary diseases that are associated with cancer, cardiovascular, obesity and autoimmune [...]

Laboratory Testing. Medical Testing. Medical Research.

Laboratory Testing. Medical Testing. Medical Research.

Ayass BioScience, LLC

8501 Wade Blvd. Bldg 9, Frisco, TX 750934

Phone: 972-668-6005

Fax: 972-635-4440

Go to Top